Works matching AU Fukutomi, Akira

Results: 70
    1

    Risk factors for aspiration pneumonia after definitive chemoradiotherapy or bio-radiotherapy for locally advanced head and neck cancer: a monocentric case control study.

    Published in:
    2017
    By:
    • Sadayuki Kawai;
    • Tomoya Yokota;
    • Yusuke Onozawa;
    • Satoshi Hamauchi;
    • Akira Fukutomi;
    • Hirofumi Ogawa;
    • Tsuyoshi Onoe;
    • Tetsuro Onitsuka;
    • Takashi Yurikusa;
    • Akiko Todaka;
    • Takahiro Tsushima;
    • Yukio Yoshida;
    • Yosuke Kito;
    • Keita Mori;
    • Hirofumi Yasui;
    • Kawai, Sadayuki;
    • Yokota, Tomoya;
    • Onozawa, Yusuke;
    • Hamauchi, Satoshi;
    • Fukutomi, Akira
    Publication type:
    journal article
    2

    Migrating Mirena.

    Published in:
    2013
    By:
    • Fukutomi, Akira;
    • De Souza, Mark
    Publication type:
    Letter
    3

    Serum CA19-9 Response Is an Early Predictive Marker of Efficacy of Regorafenib in Refractory Metastatic Colorectal Cancer.

    Published in:
    Oncology, 2017, v. 93, n. 5, p. 329, doi. 10.1159/000479280
    By:
    • Komori, azusa;
    • Taniguchi, Hiroya;
    • Hamauchi, Satoshi;
    • Masuishi, Toshiki;
    • Kito, Yosuke;
    • Narita, Yukiya;
    • Tsushima, Takahiro;
    • Ishihara, Makoto;
    • Todaka, akiko;
    • Tanaka, Tsutomu;
    • Yokota, Tomoya;
    • Kadowaki, Shigenori;
    • Machida, Nozomu;
    • Ura, Takashi;
    • Fukutomi, akira;
    • ando, Masashi;
    • Onozawa, Yusuke;
    • Tajika, Masahiro;
    • Yasui, Hirofumi;
    • Muro, Kei
    Publication type:
    Article
    4
    5
    6

    Human equilibrative nucleoside transporter‐1 expression is a predictor in patients with resected pancreatic cancer treated with adjuvant S‐1 chemotherapy.

    Published in:
    Cancer Science, 2020, v. 111, n. 2, p. 548, doi. 10.1111/cas.14258
    By:
    • Okamura, Yukiyasu;
    • Yasukawa, Satoru;
    • Narimatsu, Hiroto;
    • Boku, Narikazu;
    • Fukutomi, Akira;
    • Konishi, Masaru;
    • Morinaga, Soichiro;
    • Toyama, Hirochika;
    • Kaneoka, Yuji;
    • Shimizu, Yasuhiro;
    • Nakamori, Shoji;
    • Sata, Naohiro;
    • Yamakita, Keisuke;
    • Takahashi, Amane;
    • Kainuma, Osamu;
    • Hishinuma, Shoichi;
    • Yamaguchi, Ryuzo;
    • Nagino, Masato;
    • Hirano, Satoshi;
    • Yanagisawa, Akio
    Publication type:
    Article
    7

    Impact of UGT1A1 genetic polymorphism on toxicity in unresectable pancreatic cancer patients undergoing FOLFIRINOX.

    Published in:
    Cancer Science, 2019, v. 110, n. 2, p. 707, doi. 10.1111/cas.13883
    By:
    • Shirasu, Hiromichi;
    • Todaka, Akiko;
    • Omae, Katsuhiro;
    • Fujii, Hirofumi;
    • Mizuno, Nobumasa;
    • Ozaka, Masato;
    • Ueno, Hideki;
    • Kobayashi, Satoshi;
    • Uesugi, Kazuhiro;
    • Kobayashi, Noritoshi;
    • Hayashi, Hideyuki;
    • Sudo, Kentaro;
    • Okano, Naohiro;
    • Horita, Yosuke;
    • Kamei, Keiko;
    • Yukisawa, Seigo;
    • Kobayashi, Marina;
    • Fukutomi, Akira
    Publication type:
    Article
    8
    9
    10

    Randomized phase II/ III clinical trial of elpamotide for patients with advanced pancreatic cancer: PEGASUS- PC Study.

    Published in:
    Cancer Science, 2015, v. 106, n. 7, p. 883, doi. 10.1111/cas.12674
    By:
    • Yamaue, Hiroki;
    • Tsunoda, Takuya;
    • Tani, Masaji;
    • Miyazawa, Motoki;
    • Yamao, Kenji;
    • Mizuno, Nobumasa;
    • Okusaka, Takuji;
    • Ueno, Hideki;
    • Boku, Narikazu;
    • Fukutomi, Akira;
    • Ishii, Hiroshi;
    • Ohkawa, Shinichi;
    • Furukawa, Masayuki;
    • Maguchi, Hiroyuki;
    • Ikeda, Masafumi;
    • Togashi, Yosuke;
    • Nishio, Kazuto;
    • Ohashi, Yasuo
    Publication type:
    Article
    11
    12

    A randomized, double‐blind, phase II study of oral histone deacetylase inhibitor resminostat plus S‐1 versus placebo plus S‐1 in biliary tract cancers previously treated with gemcitabine plus platinum‐based chemotherapy.

    Published in:
    Cancer Medicine, 2021, v. 10, n. 6, p. 2088, doi. 10.1002/cam4.3813
    By:
    • Ueno, Makoto;
    • Morizane, Chigusa;
    • Furukawa, Masayuki;
    • Sakai, Daisuke;
    • Komatsu, Yoshito;
    • Nakai, Yousuke;
    • Tsuda, Masahiro;
    • Ozaka, Masato;
    • Mizuno, Nobumasa;
    • Muto, Manabu;
    • Fukutomi, Akira;
    • Ikeda, Masafumi;
    • Tsuji, Akihito;
    • Katanuma, Akio;
    • Moriwaki, Toshikazu;
    • Kajiwara, Takeshi;
    • Ishii, Hiroshi;
    • Negoro, Yuji;
    • Shimizu, Satoshi;
    • Nemoto, Noriko
    Publication type:
    Article
    13
    14
    15
    16
    17

    Randomized phase II trial of chemoradiotherapy with S‐1 versus combination chemotherapy with gemcitabine and S‐1 as neoadjuvant treatment for resectable pancreatic cancer (JASPAC 04).

    Published in:
    Journal of Hepato -- Biliary -- Pancreatic Sciences, 2023, v. 30, n. 11, p. 1249, doi. 10.1002/jhbp.1353
    By:
    • Sugiura, Teiichi;
    • Toyama, Hirochika;
    • Fukutomi, Akira;
    • Asakura, Hirofumi;
    • Takeda, Yuriko;
    • Yamamoto, Kouji;
    • Hirano, Satoshi;
    • Satoi, Sohei;
    • Matsumoto, Ippei;
    • Takahashi, Shinichiro;
    • Morinaga, Soichiro;
    • Yoshida, Makoto;
    • Sakuma, Yasunaru;
    • Iwamoto, Hidetaka;
    • Shimizu, Yasuhiro;
    • Uesaka, Katsuhiko
    Publication type:
    Article
    18
    19

    Phase II study of S-1 plus oxaliplatin 130 mg/m<sup>2</sup> in Japanese patients with advanced gastric cancer.

    Published in:
    International Journal of Clinical Oncology, 2018, v. 23, n. 6, p. 1084, doi. 10.1007/s10147-018-1308-1
    By:
    • Kito, Yosuke;
    • Machida, Nozomu;
    • Kawai, Sadayuki;
    • Hamauchi, Satoshi;
    • Tsushima, Takahiro;
    • Todaka, Akiko;
    • Yokota, Tomoya;
    • Yamazaki, Kentaro;
    • Fukutomi, Akira;
    • Onozawa, Yusuke;
    • Tsuji, Kunihiro;
    • Doyama, Hisashi;
    • Haraguchi, Yutaka;
    • Nakashima, Koji;
    • Kunieda, Kenji;
    • Taku, Keisei;
    • Mori, Keita;
    • Yasui, Hirofumi
    Publication type:
    Article
    20

    Primary prophylactic granulocyte colony-stimulating factor according to ASCO guidelines has no preventive effect on febrile neutropenia in patients treated with docetaxel, cisplatin, and 5-fluorouracil chemotherapy.

    Published in:
    International Journal of Clinical Oncology, 2018, v. 23, n. 6, p. 1189, doi. 10.1007/s10147-018-1306-3
    By:
    • Kawahira, Masahiro;
    • Yokota, Tomoya;
    • Hamauchi, Satoshi;
    • Kawai, Sadayuki;
    • Yoshida, Yukio;
    • Onozawa, Yusuke;
    • Tsushima, Takahiro;
    • Todaka, Akiko;
    • Machida, Nozomu;
    • Yamazaki, Kentaro;
    • Fukutomi, Akira;
    • Yasui, Hirofumi
    Publication type:
    Article
    21
    22
    23
    24
    25

    Leptomeningeal carcinomatosis associated with gastric cancer.

    Published in:
    International Journal of Clinical Oncology, 2012, v. 17, n. 4, p. 361, doi. 10.1007/s10147-011-0301-8
    By:
    • Tomita, Hideharu;
    • Yasui, Hirofumi;
    • Boku, Narikazu;
    • Nakasu, Yoko;
    • Mitsuya, Koichi;
    • Onozawa, Yusuke;
    • Fukutomi, Akira;
    • Yamazaki, Kentaro;
    • Machida, Nozomu;
    • Taku, Keisei;
    • Todaka, Akiko;
    • Taniguchi, Hiroya;
    • Tsushima, Takahiro
    Publication type:
    Article
    26

    Risk factors and clinical courses of chemoradiation-related arterio-esophageal fistula in esophageal cancer patients with clinical invasion of the aorta.

    Published in:
    International Journal of Clinical Oncology, 2011, v. 16, n. 4, p. 359, doi. 10.1007/s10147-011-0192-8
    By:
    • Taniguchi, Hiroya;
    • Yamazaki, Kentaro;
    • Boku, Narikazu;
    • Funakoshi, Taro;
    • Hamauchi, Satoshi;
    • Tsushima, Takahiro;
    • Todaka, Akiko;
    • Sakamoto, Takeshi;
    • Tomita, Hideharu;
    • Machida, Nozomu;
    • Taku, Keisei;
    • Fukutomi, Akira;
    • Onozawa, Yusuke;
    • Tsubosa, Yasuhiro;
    • Sato, Hiroshi;
    • Nishimura, Tetsuo;
    • Yasui, Hirofumi
    Publication type:
    Article
    27

    Comparison of combination chemotherapy with irinotecan and cisplatin regimen administered every 2 or 4 weeks in pretreated patients with unresectable or recurrent gastric cancer: retrospective analysis.

    Published in:
    International Journal of Clinical Oncology, 2010, v. 15, n. 3, p. 287, doi. 10.1007/s10147-010-0054-9
    By:
    • Sakamoto, Takeshi;
    • Yasui, Hirofumi;
    • Boku, Narikazu;
    • Onozawa, Yusuke;
    • Hironaka, Shuichi;
    • Fukutomi, Akira;
    • Yamazaki, Kentaro;
    • Taku, Keisei;
    • Machida, Nozomu;
    • Todaka, Akiko;
    • Tomita, Hideharu;
    • Tsushima, Takahiro;
    • Taniguchi, Hiroya;
    • Hamauchi, Satoshi
    Publication type:
    Article
    28
    29

    A retrospective study of second-line chemotherapy for unresectable or recurrent squamous cell carcinoma of the esophagus refractory to chemotherapy with 5-fluorouracil plus platinum.

    Published in:
    International Journal of Clinical Oncology, 2008, v. 13, n. 2, p. 150, doi. 10.1007/s10147-007-0738-y
    By:
    • Yamazaki, Kentaro;
    • Hironaka, Shuichi;
    • Boku, Narikazu;
    • Yasui, Hirofumi;
    • Fukutomi, Akira;
    • Yoshino, Takayuki;
    • Onozawa, Yusuke;
    • Hasuike, Noriaki;
    • Inui, Tetsuya;
    • Yamaguchi, Yuichiro;
    • Ono, Hiroyuki
    Publication type:
    Article
    30
    31

    Results of a retrospective analysis of gemcitabine as a second-line treatment after chemoradiotherapy and maintenance chemotherapy using 5-fluorouracil in patients with locally advanced pancreatic cancer.

    Published in:
    Journal of Gastroenterology, 2008, v. 43, n. 11, p. 875, doi. 10.1007/s00535-008-2236-z
    By:
    • Taira, Koichi;
    • Boku, Narikazu;
    • Fukutomi, Akira;
    • Onozawa, Yusuke;
    • Hironaka, Shuichi;
    • Yoshino, Takayuki;
    • Yasui, Hirofumi;
    • Yamazaki, Kentaro;
    • Taku, Keisei;
    • Hashimoto, Takayuki;
    • Nishimura, Tetsuo
    Publication type:
    Article
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41

    Randomized phase II study of chemoradiotherapy with versus without induction chemotherapy for locally advanced pancreatic cancer: Japan Clinical Oncology Group trial, JCOG1106.

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 2, p. 235, doi. 10.1093/jjco/hyaa198
    By:
    • Ioka, Tatsuya;
    • Furuse, Junji;
    • Fukutomi, Akira;
    • Mizusawa, Junki;
    • Nakamura, Satoaki;
    • Hiraoka, Nobuyoshi;
    • Ito, Yoshinori;
    • Katayama, Hiroshi;
    • Ueno, Makoto;
    • Ikeda, Masafumi;
    • Sugimori, Kazuya;
    • Okano, Naohiro;
    • Shimizu, Kyoko;
    • Yanagimoto, Hiroaki;
    • Okusaka, Takuji;
    • Ozaka, Masato;
    • Todaka, Akiko;
    • Nakamori, Shoji;
    • Tobimatsu, Kazutoshi;
    • Sata, Naohiro
    Publication type:
    Article
    42

    Comparison of enteral nutrition with total parenteral nutrition for patients with locally advanced unresectable esophageal cancer harboring dysphagia in definitive chemoradiotherapy.

    Published in:
    Japanese Journal of Clinical Oncology, 2019, v. 49, n. 10, p. 910, doi. 10.1093/jjco/hyz089
    By:
    • Furuta, Mitsuhiro;
    • Yokota, Tomoya;
    • Tsushima, Takahiro;
    • Todaka, Akiko;
    • Machida, Nozomu;
    • Hamauchi, Satoshi;
    • Yamazaki, Kentaro;
    • Fukutomi, Akira;
    • Kawai, Sadayuki;
    • Kawabata, Takanori;
    • Onozawa, Yusuke;
    • Yasui, Hirofumi
    Publication type:
    Article
    43
    44

    Safety, Tolerability, Pharmacokinetics and Antitumor Activity of Ganitumab, an Investigational Fully Human Monoclonal Antibody to Insulin-like Growth Factor Type 1 Receptor, Combined with Gemcitabine as First-line Therapy in Patients with Metastatic ...

    Published in:
    Japanese Journal of Clinical Oncology, 2014, v. 44, n. 5, p. 442, doi. 10.1093/jjco/hyu034
    By:
    • Okusaka, Takuji;
    • Ikeda, Masafumi;
    • Fukutomi, Akira;
    • Kobayashi, Yoshikazu;
    • Shibayama, Kazuhiro;
    • Takubo, Takatoshi;
    • Gansert, Jennifer
    Publication type:
    Article
    45
    46
    47
    48
    49
    50